TRIUMF-partnered ARTMS a finalist for 2017 Technology Impact Awards

TRIUMF-partnered ARTMS Products Inc. is a People's Choice finalist for the BC Tech Association’s 2017 Technology Impact Awards. Learn more - including where to vote - here.

ALPHA shines light on antimatter question

ALPHA collaboration reports on the first spectroscopic laser measurement of antimatter atoms

Developing TRIUMF's Five-Year Plan 2020-25

TRIUMF is starting to prepare its Five-Year Plan 2020-2025. Details here

A custom-made revolution for isotope beamlines

Deep in the basement of TRIUMF’s Advanced Rare IsotopE Laboratory (ARIEL), a new age for accelerator science-based research in Canada is taking shape

Introducing TRIUMF Innovations

TRIUMF announces the formation of TRIUMF Innovations, the laboratory’s new commercialization arm. Read more.


06 April 2017 -  TRIUMF announces the formation of TRIUMF Innovations, the laboratory’s new commercialization arm. 

13 March 2017 -  TRIUMF is pleased to announce the recent appointment of Dr. Digvir S. Jayas as Chair of the Board of Management

01 February 2017 -  TRIUMF is pleased to announce the appointment of Ms. Kathryn Hayashi as President and CEO of the laboratory’s non-profit commercialization arm, Advanced Applied Physics Solutions Inc. (AAPS). Hayashi will assume leadership of AAPS effective February 6, 2017.

Subscribe to TRIUMF Headlines

Research Highlights

19 May 2017 -  ARTMS Products Inc., Vancouver-based medical technology company that emerged from a TRIUMF-led consortium, has been selected as a finalist for the BC Tech Association’s 2017 Technology Impact Awards.

26 April 2017 -  The ARIEL facility reached a milestone in December 2016 with the successful installation of a 15-metre prototype of the Rare Isotope Beam (RIB) transport system.

31 January 2017 -   In December 2016, EMMA  achieved a major breakthrough when it was tested for the first time with a heavy ion beam.

Subscribe to TRIUMF Research Highlights